Dr David Roblin
Dr. David Roblin is the chief executive of Relation Therapeutics, a London-based biotechnology company, and he has highlighted the UK’s strong academic environment and research capabilities while discussing the impacts of Merck's decision to withdraw investment from the UK.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 6.00 | 0.04% | +0% | 67,886,011 | 28,584 | $2,700,000 | 1,137$ |
| Totals | 1 | 67,886,011 | 28,584 | $2,700,000 | 1,137$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Dr David Roblin is the chief executive of Relation Therapeutics who discussed the UK's academic environment for innovation.
6